Shun-Fa Yang

Author PubWeight™ 17.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 ADAMTS14 Gene Polymorphism and Environmental Risk in the Development of Oral Cancer. PLoS One 2016 0.87
2 Upregulation of miR-328 and inhibition of CREB-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomas. Oncotarget 2015 0.86
3 By inhibiting snail signaling and miR-23a-3p, osthole suppresses the EMT-mediated metastatic ability in prostate cancer. Oncotarget 2015 0.84
4 Cancer metastasis: Mechanisms of inhibition by melatonin. J Pineal Res 2016 0.82
5 Analysis of Associations of Human BAFF Gene Polymorphisms with Autoimmune Thyroid Diseases. PLoS One 2016 0.82
6 Functional genetic variant in the Kozak sequence of WW domain-containing oxidoreductase (WWOX) gene is associated with oral cancer risk. Oncotarget 2016 0.82
7 Effect of CD44 gene polymorphisms on risk of transitional cell carcinoma of the urinary bladder in Taiwan. Tumour Biol 2015 0.81
8 Melatonin inhibits TPA-induced oral cancer cell migration by suppressing matrix metalloproteinase-9 activation through the histone acetylation. Oncotarget 2016 0.81
9 Cathepsin B Expression and the Correlation with Clinical Aspects of Oral Squamous Cell Carcinoma. PLoS One 2016 0.80
10 Serpin peptidase inhibitor (SERPINB5) haplotypes are associated with susceptibility to hepatocellular carcinoma. Sci Rep 2016 0.80
11 Resveratrol suppresses TPA-induced matrix metalloproteinase-9 expression through the inhibition of MAPK pathways in oral cancer cells. J Oral Pathol Med 2014 0.79
12 The role of liver transplantation or resection for patients with early hepatocellular carcinoma. Tumour Biol 2015 0.78
13 Association of matrix metalloproteinase-11 polymorphisms with susceptibility and clinicopathologic characteristics for oral squamous cell carcinoma. Head Neck 2014 0.78
14 Combined effect of genetic polymorphisms of AURKA and environmental factors on oral cancer development in Taiwan. PLoS One 2017 0.77
15 Association of intercellular adhesion molecule-1 single nucleotide polymorphisms with hepatocellular carcinoma susceptibility and clinicopathologic development. Tumour Biol 2015 0.77
16 Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-κB DNA-binding activity. J Pineal Res 2016 0.77
17 Expression of myeloid zinc finger 1 and the correlation to clinical aspects of oral squamous cell carcinoma. Tumour Biol 2015 0.76
18 Exome Sequencing of Oral Squamous Cell Carcinoma Reveals Molecular Subgroups and Novel Therapeutic Opportunities. Theranostics 2017 0.75
19 Effects of ADAMTS14 genetic polymorphism and cigarette smoking on the clinicopathologic development of hepatocellular carcinoma. PLoS One 2017 0.75
20 Effect of genetic variation in microRNA binding site in WNT1-inducible signaling pathway protein 1 gene on oral squamous cell carcinoma susceptibility. PLoS One 2017 0.75
21 Risk of pneumonia in patients with isolated minor rib fractures: a nationwide cohort study. BMJ Open 2017 0.75
22 Combinations of SERPINB5 gene polymorphisms and environmental factors are associated with oral cancer risks. PLoS One 2017 0.75
23 Reply to: Re: Proton Pump Inhibitor Usage and Risk of Pneumonia in Dementia Patients. J Am Geriatr Soc 2017 0.75
24 Evaluating the Prognostic Value of ERCC1 and Thymidylate Synthase Expression and the Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma Non-Small-Cell Lung Cancer. Int J Med Sci 2017 0.75
25 High Level of Plasma EGFL6 Is Associated with Clinicopathological Characteristics in Patients with Oral Squamous Cell Carcinoma. Int J Med Sci 2017 0.75
26 Functional FGFR4 Gly388Arg polymorphism contributes to oral squamous cell carcinoma susceptibility. Oncotarget 2017 0.75
27 Geraniin inhibits oral cancer cell migration by suppressing matrix metalloproteinase-2 activation through the FAK/Src and ERK pathways. Environ Toxicol 2019 0.75
28 Melatonin-triggered post-transcriptional and post-translational modifications of ADAMTS1 coordinately retard tumorigenesis and metastasis of renal cell carcinoma. J Pineal Res 2020 0.75
29 Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients. J Am Geriatr Soc 2017 0.75
30 Tricetin suppresses human oral cancer cell migration by reducing matrix metalloproteinase-9 expression through the mitogen-activated protein kinase signaling pathway. Environ Toxicol 2017 0.75
31 Rubus idaeus extract suppresses migration and invasion of human oral cancer by inhibiting MMP-2 through modulation of the Erk1/2 signaling pathway. Environ Toxicol 2016 0.75
32 Impact of CCL4 gene polymorphisms and environmental factors on oral cancer development and clinical characteristics. Oncotarget 2017 0.75
33 Inhibitory effects of Leucaena leucocephala on the metastasis and invasion of human oral cancer cells. Environ Toxicol 2017 0.75
34 Antimetastatic effects of Rheum palmatum L. extract on oral cancer cells. Environ Toxicol 2017 0.75
35 Associations of melatonin receptor gene polymorphisms with Graves' disease. PLoS One 2017 0.75
36 Pneumonia is an independent risk factor for pyogenic liver abscess: A population-based, nested, case-control study. PLoS One 2017 0.75
37 Hispolon suppresses migration and invasion of human nasopharyngeal carcinoma cells by inhibiting the urokinase-plasminogen activator through modulation of the Akt signaling pathway. Environ Toxicol 2016 0.75
38 Independent Prognostic Value of Hypoxia-inducible Factor 1-alpha Expression in Small Cell Lung Cancer. Int J Med Sci 2017 0.75
39 Quercetin simultaneously induces G0 /G1 -phase arrest and caspase-mediated crosstalk between apoptosis and autophagy in human leukemia HL-60 cells. Environ Toxicol 2017 0.75
40 Hispolon suppresses metastasis via autophagic degradation of cathepsin S in cervical cancer cells. Cell Death Dis 2017 0.75
41 Epigallocatechin-3-gallate inhibits migration of human nasopharyngeal carcinoma cells by repressing MMP-2 expression. J Cell Physiol 2019 0.75
42 The potential utility of melatonin in the treatment of childhood cancer. J Cell Physiol 2019 0.75